COVID-19 Serology Testing

This test can be used as an aid in diagnosing SARS-CoV-2 infections when RT-PCR is not used as a first-line diagnostic tool, as when samples are collected more than 8 days after symptom onset. The test can also be used for suspected COVID-19 infections, particularly in patients hospitalized with severe symptoms who have tested negative with RT-PCR.

EVOLIS Automated Testing Platforms

The Platelia SARS-CoV-2 Total Ab assay can be used with automated and manual immunoassay systems for the detection of anti-SARS-CoV-2 IgM, IgA and IgG. While the assay is recommended for use on the Bio-Rad validated, fully-automated EVOLIS Systems or stand-alone systems (IPS/PR4100/PW40), it can also be run on other validated manual or automated platforms.

The Platelia SARS-CoV-2 Total Ab assay detects total anti-nucleocapsid antibodies (IgM, IgA, and IgG) to SARS-CoV-2 with sensitivity of 97.5%, for patients tested >8 days after symptom onset.